MRI contrast agents, where do we come from, where are we going to?
International Contrast Media Research Symposium—Program
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 65 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1555-4309
- DOI
- 10.1002/cmmi.1
No coin nor oath required. For personal study only.
✦ Synopsis
A. Cue ´nod 1.01 V. Lorusso: The hepatobiliary excretion of Gd-BOPTA does not interfere with the clearance of other drugs. 1.02 S. Hirohashi: Extraction rate of SPIO by the normal and gadolinium chloride-treated liver. 1.03 E. Lee: Analysis of hepatic uptake of anionic magnetic nanoparticles. 1.04 J. Schnorr: Comparison of VSOP-C184, gadopentetate dimeglumine and ferucarbotran in T 1 -weighted dynamic and T 2 -weighted late MRI of focal liver lesions in rabbits. 1.05 C. Wirth: Does dual-contrast MRI of the liver improve the detection of focal liver lesions? On-site results of a prospective multicenter study. 1.06 R. Kuwatsuru: Comparison of liver metastasis detectability from colorectal cancer between SPIO-MRI and diffusion-weighted imaging.
📜 SIMILAR VOLUMES
Early stages investigation of USPIO-induced signal loss after focal cerebral ischemia in mice J. Marsh: Potential of streptokinase-activated nanoparticles for early revascularization in acute ischemic stroke P. Caravan: Molecular MR imaging of myocardial collagen and assessment of myocardial perfusi